Niki BioSolutions, Inc. NIKI
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.19
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $431.4K | $1.3M | $1.5M | — | — | — | — | — |
| Cost of revenue | — | — | $420.8K | $1.2M | $1.5M | — | — | — | — | — |
| Gross profit | — | — | $10.6K | $80.1K | $81.9K | — | — | — | — | — |
| R&D | $352.9K | $2.2M | $5.2M | $9.2M | $10.9M | $11.6M | $6.9M | $3.1M | — | — |
| SG&A | $573.1K | $669.5K | $1.9M | $5.2M | $5.4M | $4.9M | $7.4M | $4.9M | — | — |
| Total operating expenses | — | $3.9M | $31.0K | $18.8M | $20.7M | $21.2M | $18.7M | $10.7M | — | — |
| Pre-tax income | -$1.4M | -$4.2M | -$4.3M | — | — | — | — | — | — | — |
| Net income | -$1.4M | -$4.3M | -$2.8M | -$9.8M | -$25.0M | $4.9M | -$20.1M | -$14.8M | — | — |
| EPS, basic | -0.19 | -0.78 | -0.62 | -2.75 | -7.15 | 2.03 | -0.64 | — | — | — |
| EPS, diluted | -0.19 | -0.78 | -0.62 | -2.75 | -7.15 | 2.00 | -0.64 | -0.53 | — | — |
| Shares, diluted (wtd. avg.) | 7.4M | 5.5M | 4.5M | 3.6M | 3.5M | 3.2M | 29.0M | 27.9M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.5M | $874.2K | $2.0M | $5.0M | $8.3M | $3.6M | $5.3M | $26.1M | $16.7M | $623.8K |
| Short-term investments | — | — | — | $102.5K | $236.6K | — | $1.1M | $1.0M | $2.0M | — |
| Receivables | — | — | $47.7K | $174.4K | $78.7K | $62.2K | $40.5K | $2.8K | — | — |
| Inventory | — | — | — | $27.7K | $35.8K | $39.1K | $34.2K | $30.6K | — | — |
| Total current assets | $3.6M | $959.6K | $2.5M | $7.1M | $12.7M | $33.7M | $8.0M | $28.7M | $20.3M | — |
| Property, plant and equipment | — | — | $1.7M | $2.8M | $3.7M | $4.7M | $7.1M | $4.3M | $346.6K | — |
| Other intangibles | — | — | $147.3K | $752.7K | $880.3K | $964.9K | $1.3M | $1.4M | $1.5M | — |
| Total assets | $18.7M | $16.1M | $20.6M | $20.9M | $21.9M | $44.2M | $24.0M | $45.1M | $31.6M | — |
| Accounts payable | $1.1M | $918.6K | $1.9M | $6.2M | $4.2M | $3.2M | $2.6M | — | — | — |
| Total current liabilities | $4.6M | $4.3M | $2.1M | $12.5M | $4.4M | $3.9M | $2.7M | $12.2M | $1.3M | — |
| Long-term debt | — | — | — | $129.8K | $296.2K | $296.2K | $294.6K | $3.4M | $1.8M | — |
| Total liabilities | $4.9M | $4.4M | $5.3M | $13.0M | $4.4M | $6.1M | $9.1M | $12.3M | $1.3M | — |
| Retained earnings | -$73.8M | -$72.4M | -$68.2M | -$65.3M | -$55.5M | -$30.5M | -$37.6M | -$17.4M | -$2.5M | — |
| Total equity | $23.1M | $21.1M | $15.4M | $7.8M | $17.5M | $38.2M | $14.9M | $32.7M | $30.2M | $24.5M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.8M | -$1.2M | -$7.7M | -$12.3M | -$14.7M | -$15.9M | -$13.4M | -$10.0M | — | — |
| Depreciation and amortisation | — | $235.8K | $1.0M | $1.1M | $1.2M | $1.3M | $1.3M | $682.3K | — | — |
| Stock-based compensation | — | — | $1.3M | $1.6M | $1.7M | $1.5M | $1.6M | — | — | — |
| Capital expenditure | — | — | $3.0K | $186.9K | $131.8K | $161.3K | $837.1K | $5.6M | — | — |
| Investing cash flow | — | $58.6K | $624.8K | $2.4M | $16.5M | $1.8M | -$108.1K | -$6.1M | — | — |
| Financing cash flow | $4.4M | — | $4.1M | $6.6M | $2.8M | $12.4M | -$7.3M | $25.5M | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-054062.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1.5M | $1.3M | $431.4K | — | — |
| Gross profit | — | — | — | — | — | $81.9K | $80.1K | $10.6K | — | — |
| Net income | — | — | -$14.8M | -$20.1M | $4.9M | -$25.0M | -$9.8M | -$2.8M | -$4.3M | -$1.4M |
Recent filings and events
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
- Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
- Officer or director change Item 5.02
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Other event Item 8.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3829
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC. | $249.14B | 38.0x | 3.9% |
| ROK | ROCKWELL AUTOMATION, INC | $47.32B | 55.6x | 0.9% |
| TRMB | TRIMBLE INC. | $14.80B | 36.1x | -2.6% |
| ONTO | ONTO INNOVATION INC. | $9.75B | 71.5x | 1.8% |
| MIR | Mirion Technologies, Inc. | $3.62B | 134.6x | 7.5% |
| QSI | Quantum-Si Inc | $304.9M | — | -20.3% |
| OWLT | Owlet, Inc. | $119.8M | — | 35.4% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | $55.1M | — | -18.3% |